Status:
UNKNOWN
Single Shot Intrathecal Analgesia in Vaginal Delivery
Lead Sponsor:
Ain Shams University
Conditions:
Effectiveness of Single Shot Intra-thecal Analgesia in Multiparous Women Scheduled for Normal Vaginal Delivery
Eligibility:
FEMALE
22-45 years
Phase:
NA
Brief Summary
Effectiveness of single shot intra-thecal analgesia in multiparous women scheduled for normal vaginal delivery
Detailed Description
Labor is a physiological and natural process, as well as a complicated and subjective experience.Except for a few women, childbirth is unquestionably a painful experience. Women's understanding of del...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Multiparous women who received antenatal care, presented for vaginal delivery of uncomplicated term pregnancy of singleton fetus with engaged fetal head and cervical dilatation of at least 5 cm requiring oxytocin augmentation, and requested analgesia.
- Age: patients between 22-45 years old.
- Exclusion criteria:
- Refusal of procedure or participation in the study.
- Patients with pre-existing or pregnancy-induced hypertension, abnormal fetal heart rate tracings, obesity, endocrinal diseases and/or diagnosed fetal abnormalities.
- Contraindication to neuraxial block.
- Allergy to any of the study drugs.
Exclusion
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT05998551
Start Date
January 1 2023
End Date
October 1 2023
Last Update
August 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ainshams University
Cairo, Egypt